Report Cover

Global and United States Influenza Vaccines Market Insights, Forecast to 2026


Influenza Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Influenza Vaccines market is segmented into
    Trivalent Flu Vaccines
    Quadrivalent Flu Vaccines

Segment by Application, the Influenza Vaccines market is segmented into
    Adults
    Pediatrics

Regional and Country-level Analysis
The Influenza Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Influenza Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Influenza Vaccines Market Share Analysis
Influenza Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Vaccines business, the date to enter into the Influenza Vaccines market, Influenza Vaccines product introduction, recent developments, etc.
The major vendors covered:
    AstraZeneca
    CSL
    GlaxoSmithKline
    Sanofi
    Altimmune
    BionVax
    FluGen
    FOLIA BIOTECH
    Genentech
    Green Cross
    Medicago
    Moderna Therapeutics
    Novavax
    Shijiazhuang Yiling Pharmaceutical
    SK Chemicals
    UNM Pharma
    Vaccitech
    Vaxart
    Vaxine Pty
    Visterra
1 Study Coverage
    1.1 Influenza Vaccines Product Introduction
    1.2 Market Segments
    1.3 Key Influenza Vaccines Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type
        1.4.2 Trivalent Flu Vaccines
        1.4.3 Quadrivalent Flu Vaccines
    1.5 Market by Application
        1.5.1 Global Influenza Vaccines Market Size Growth Rate by Application
        1.5.2 Adults
        1.5.3 Pediatrics
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Influenza Vaccines Market Size, Estimates and Forecasts
        2.1.1 Global Influenza Vaccines Revenue 2015-2026
        2.1.2 Global Influenza Vaccines Sales 2015-2026
    2.2 Global Influenza Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Influenza Vaccines Historical Market Size by Region (2015-2020)
        2.3.1 Global Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Influenza Vaccines Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Influenza Vaccines Sales Forecast by Region (2021-2026)
        2.4.2 Global Influenza Vaccines Revenue Forecast by Region (2021-2026)

3 Global Influenza Vaccines Competitor Landscape by Players
    3.1 Global Top Influenza Vaccines Sales by Manufacturers
        3.1.1 Global Influenza Vaccines Sales by Manufacturers (2015-2020)
        3.1.2 Global Influenza Vaccines Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Influenza Vaccines Manufacturers by Revenue
        3.2.1 Global Influenza Vaccines Revenue by Manufacturers (2015-2020)
        3.2.2 Global Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Influenza Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Influenza Vaccines Revenue in 2019
        3.2.5 Global Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Influenza Vaccines Price by Manufacturers
    3.4 Global Influenza Vaccines Manufacturing Base Distribution, Product Types
        3.4.1 Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Influenza Vaccines Product Type
        3.4.3 Date of International Manufacturers Enter into Influenza Vaccines Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Influenza Vaccines Market Size by Type (2015-2020)
        4.1.1 Global Influenza Vaccines Sales by Type (2015-2020)
        4.1.2 Global Influenza Vaccines Revenue by Type (2015-2020)
        4.1.3 Influenza Vaccines Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Influenza Vaccines Market Size Forecast by Type (2021-2026)
        4.2.1 Global Influenza Vaccines Sales Forecast by Type (2021-2026)
        4.2.2 Global Influenza Vaccines Revenue Forecast by Type (2021-2026)
        4.2.3 Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Influenza Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Influenza Vaccines Market Size by Application (2015-2020)
        5.1.1 Global Influenza Vaccines Sales by Application (2015-2020)
        5.1.2 Global Influenza Vaccines Revenue by Application (2015-2020)
        5.1.3 Influenza Vaccines Price by Application (2015-2020)
    5.2 Influenza Vaccines Market Size Forecast by Application (2021-2026)
        5.2.1 Global Influenza Vaccines Sales Forecast by Application (2021-2026)
        5.2.2 Global Influenza Vaccines Revenue Forecast by Application (2021-2026)
        5.2.3 Global Influenza Vaccines Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
    6.1 United States Influenza Vaccines Market Size YoY Growth 2015-2026
        6.1.1 United States Influenza Vaccines Sales YoY Growth 2015-2026
        6.1.2 United States Influenza Vaccines Revenue YoY Growth 2015-2026
        6.1.3 United States Influenza Vaccines Market Share in Global Market 2015-2026
    6.2 United States Influenza Vaccines Market Size by Players (International and Local Players)
        6.2.1 United States Top Influenza Vaccines Players by Sales (2015-2020)
        6.2.2 United States Top Influenza Vaccines Players by Revenue (2015-2020)
    6.3 United States Influenza Vaccines Historic Market Review by Type (2015-2020)
        6.3.1 United States Influenza Vaccines Sales Market Share by Type (2015-2020)
        6.3.2 United States Influenza Vaccines Revenue Market Share by Type (2015-2020)
        6.3.3 United States Influenza Vaccines Price by Type (2015-2020)
    6.4 United States Influenza Vaccines Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 United States Influenza Vaccines Sales Forecast by Type (2021-2026)
        6.4.2 United States Influenza Vaccines Revenue Forecast by Type (2021-2026)
        6.4.3 United States Influenza Vaccines Price Forecast by Type (2021-2026)
    6.5 United States Influenza Vaccines Historic Market Review by Application (2015-2020)
        6.5.1 United States Influenza Vaccines Sales Market Share by Application (2015-2020)
        6.5.2 United States Influenza Vaccines Revenue Market Share by Application (2015-2020)
        6.5.3 United States Influenza Vaccines Price by Application (2015-2020)
    6.6 United States Influenza Vaccines Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 United States Influenza Vaccines Sales Forecast by Application (2021-2026)
        6.6.2 United States Influenza Vaccines Revenue Forecast by Application (2021-2026)
        6.6.3 United States Influenza Vaccines Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Influenza Vaccines Market Size YoY Growth 2015-2026
    7.2 North America Influenza Vaccines Market Facts & Figures by Country
        7.2.1 North America Influenza Vaccines Sales by Country (2015-2020)
        7.2.2 North America Influenza Vaccines Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Influenza Vaccines Market Size YoY Growth 2015-2026
    8.2 Europe Influenza Vaccines Market Facts & Figures by Country
        8.2.1 Europe Influenza Vaccines Sales by Country
        8.2.2 Europe Influenza Vaccines Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Influenza Vaccines Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Influenza Vaccines Market Facts & Figures by Country
        9.2.1 Asia Pacific Influenza Vaccines Sales by Region (2015-2020)
        9.2.2 Asia Pacific Influenza Vaccines Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Influenza Vaccines Market Size YoY Growth 2015-2026
    10.2 Latin America Influenza Vaccines Market Facts & Figures by Country
        10.2.1 Latin America Influenza Vaccines Sales by Country
        10.2.2 Latin America Influenza Vaccines Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Influenza Vaccines Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Influenza Vaccines Market Facts & Figures by Country
        11.2.1 Middle East and Africa Influenza Vaccines Sales by Country
        11.2.2 Middle East and Africa Influenza Vaccines Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 AstraZeneca
        12.1.1 AstraZeneca Corporation Information
        12.1.2 AstraZeneca Description and Business Overview
        12.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 AstraZeneca Influenza Vaccines Products Offered
        12.1.5 AstraZeneca Recent Development
    12.2 CSL
        12.2.1 CSL Corporation Information
        12.2.2 CSL Description and Business Overview
        12.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 CSL Influenza Vaccines Products Offered
        12.2.5 CSL Recent Development
    12.3 GlaxoSmithKline
        12.3.1 GlaxoSmithKline Corporation Information
        12.3.2 GlaxoSmithKline Description and Business Overview
        12.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 GlaxoSmithKline Influenza Vaccines Products Offered
        12.3.5 GlaxoSmithKline Recent Development
    12.4 Sanofi
        12.4.1 Sanofi Corporation Information
        12.4.2 Sanofi Description and Business Overview
        12.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Sanofi Influenza Vaccines Products Offered
        12.4.5 Sanofi Recent Development
    12.5 Altimmune
        12.5.1 Altimmune Corporation Information
        12.5.2 Altimmune Description and Business Overview
        12.5.3 Altimmune Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Altimmune Influenza Vaccines Products Offered
        12.5.5 Altimmune Recent Development
    12.6 BionVax
        12.6.1 BionVax Corporation Information
        12.6.2 BionVax Description and Business Overview
        12.6.3 BionVax Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 BionVax Influenza Vaccines Products Offered
        12.6.5 BionVax Recent Development
    12.7 FluGen
        12.7.1 FluGen Corporation Information
        12.7.2 FluGen Description and Business Overview
        12.7.3 FluGen Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 FluGen Influenza Vaccines Products Offered
        12.7.5 FluGen Recent Development
    12.8 FOLIA BIOTECH
        12.8.1 FOLIA BIOTECH Corporation Information
        12.8.2 FOLIA BIOTECH Description and Business Overview
        12.8.3 FOLIA BIOTECH Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 FOLIA BIOTECH Influenza Vaccines Products Offered
        12.8.5 FOLIA BIOTECH Recent Development
    12.9 Genentech
        12.9.1 Genentech Corporation Information
        12.9.2 Genentech Description and Business Overview
        12.9.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 Genentech Influenza Vaccines Products Offered
        12.9.5 Genentech Recent Development
    12.10 Green Cross
        12.10.1 Green Cross Corporation Information
        12.10.2 Green Cross Description and Business Overview
        12.10.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 Green Cross Influenza Vaccines Products Offered
        12.10.5 Green Cross Recent Development
    12.11 AstraZeneca
        12.11.1 AstraZeneca Corporation Information
        12.11.2 AstraZeneca Description and Business Overview
        12.11.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 AstraZeneca Influenza Vaccines Products Offered
        12.11.5 AstraZeneca Recent Development
    12.12 Moderna Therapeutics
        12.12.1 Moderna Therapeutics Corporation Information
        12.12.2 Moderna Therapeutics Description and Business Overview
        12.12.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
        12.12.4 Moderna Therapeutics Products Offered
        12.12.5 Moderna Therapeutics Recent Development
    12.13 Novavax
        12.13.1 Novavax Corporation Information
        12.13.2 Novavax Description and Business Overview
        12.13.3 Novavax Sales, Revenue and Gross Margin (2015-2020)
        12.13.4 Novavax Products Offered
        12.13.5 Novavax Recent Development
    12.14 Shijiazhuang Yiling Pharmaceutical
        12.14.1 Shijiazhuang Yiling Pharmaceutical Corporation Information
        12.14.2 Shijiazhuang Yiling Pharmaceutical Description and Business Overview
        12.14.3 Shijiazhuang Yiling Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
        12.14.4 Shijiazhuang Yiling Pharmaceutical Products Offered
        12.14.5 Shijiazhuang Yiling Pharmaceutical Recent Development
    12.15 SK Chemicals
        12.15.1 SK Chemicals Corporation Information
        12.15.2 SK Chemicals Description and Business Overview
        12.15.3 SK Chemicals Sales, Revenue and Gross Margin (2015-2020)
        12.15.4 SK Chemicals Products Offered
        12.15.5 SK Chemicals Recent Development
    12.16 UNM Pharma
        12.16.1 UNM Pharma Corporation Information
        12.16.2 UNM Pharma Description and Business Overview
        12.16.3 UNM Pharma Sales, Revenue and Gross Margin (2015-2020)
        12.16.4 UNM Pharma Products Offered
        12.16.5 UNM Pharma Recent Development
    12.17 Vaccitech
        12.17.1 Vaccitech Corporation Information
        12.17.2 Vaccitech Description and Business Overview
        12.17.3 Vaccitech Sales, Revenue and Gross Margin (2015-2020)
        12.17.4 Vaccitech Products Offered
        12.17.5 Vaccitech Recent Development
    12.18 Vaxart
        12.18.1 Vaxart Corporation Information
        12.18.2 Vaxart Description and Business Overview
        12.18.3 Vaxart Sales, Revenue and Gross Margin (2015-2020)
        12.18.4 Vaxart Products Offered
        12.18.5 Vaxart Recent Development
    12.19 Vaxine Pty
        12.19.1 Vaxine Pty Corporation Information
        12.19.2 Vaxine Pty Description and Business Overview
        12.19.3 Vaxine Pty Sales, Revenue and Gross Margin (2015-2020)
        12.19.4 Vaxine Pty Products Offered
        12.19.5 Vaxine Pty Recent Development
    12.20 Visterra
        12.20.1 Visterra Corporation Information
        12.20.2 Visterra Description and Business Overview
        12.20.3 Visterra Sales, Revenue and Gross Margin (2015-2020)
        12.20.4 Visterra Products Offered
        12.20.5 Visterra Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Influenza Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Influenza Vaccines Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Influenza Vaccines Market Segments Table 2. Ranking of Global Top Influenza Vaccines Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Influenza Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Trivalent Flu Vaccines Table 5. Major Manufacturers of Quadrivalent Flu Vaccines Table 6. Global Influenza Vaccines Market Size Growth Rate by Application 2020-2026 (K Units) Table 7. Global Influenza Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 8. Global Influenza Vaccines Sales by Regions 2015-2020 (K Units) Table 9. Global Influenza Vaccines Sales Market Share by Regions (2015-2020) Table 10. Global Influenza Vaccines Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Influenza Vaccines Sales Forecast by Region (2021-2026) (K Units) Table 12. Global Influenza Vaccines Sales by Manufacturers (2015-2020) (K Units) Table 13. Global Influenza Vaccines Sales Share by Manufacturers (2015-2020) Table 14. Global Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 15. Global Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccines as of 2019) Table 16. Influenza Vaccines Revenue by Manufacturers (2015-2020) (US$ Million) Table 17. Influenza Vaccines Revenue Share by Manufacturers (2015-2020) Table 18. Key Manufacturers Influenza Vaccines Price (2015-2020) (USD/Unit) Table 19. Influenza Vaccines Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Influenza Vaccines Product Type Table 21. Date of International Manufacturers Enter into Influenza Vaccines Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Global Influenza Vaccines Sales by Type (2015-2020) (K Units) Table 24. Global Influenza Vaccines Sales Share by Type (2015-2020) Table 25. Global Influenza Vaccines Revenue by Type (2015-2020) (US$ Million) Table 26. Global Influenza Vaccines Revenue Share by Type (2015-2020) Table 27. Influenza Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 28. Global Influenza Vaccines Sales Share by Type (2021-2026) Table 29. Global Influenza Vaccines Sales by Application (2015-2020) (K Units) Table 30. Global Influenza Vaccines Sales Share by Application (2015-2020) Table 31. Global Influenza Vaccines Sales Share by Application (2021-2026) Table 32. Global Influenza Vaccines Sales Market Share Forecast by Application (2021-2026) Table 33. Global Influenza Vaccines Revenue by Application (2015-2020) (US$ Million) Table 34. Global Influenza Vaccines Revenue Market Share Forecast by Application (2021-2026) Table 35. United States Influenza Vaccines Sales (K Units) of Key Companies (2015-2020) Table 36. United States Influenza Vaccines Sales Share by Company (2015-2020) Table 37. United States Influenza Vaccines Revenue (US$ Million) by Company (2015-2020) Table 38. United States Influenza Vaccines Sales (K Units) by Type (2015-2020) Table 39. United States Influenza Vaccines Sales Share by Type (2015-2020) Table 40. United States Influenza Vaccines Revenue (US$ Million) Market Share by Type (2015-2020) Table 41. United States Influenza Vaccines Price (K Units) by Type (2015-2020) Table 42. United States Influenza Vaccines Sales (K Units) by Type (2021-2026) Table 43. United States Influenza Vaccines Sales Share by Type (2021-2026) Table 44. United States Influenza Vaccines Revenue (US$ Million) Market Share by Type (2021-2026) Table 45. United States Influenza Vaccines Revenue Share by Type (2021-2026) Table 46. United States Influenza Vaccines Price (K Units) by Type (2021-2026) Table 47. United States Influenza Vaccines Sales (K Units) by Application (2015-2020) Table 48. United States Influenza Vaccines Sales Share by Application (2015-2020) Table 49. United States Influenza Vaccines Revenue (US$ Million) Market Share by Application (2015-2020) Table 50. United States Influenza Vaccines Sales (K Units) by Application (2021-2026) Table 51. United States Influenza Vaccines Sales Share by Application (2021-2026) Table 52. United States Influenza Vaccines Revenue (US$ Million) Market Share by Application (2021-2026) Table 53. United States Influenza Vaccines Revenue Share by Application (2021-2026) Table 54. North America Influenza Vaccines Sales by Country (2015-2020) (K Units) Table 55. North America Influenza Vaccines Sales Market Share by Country (2015-2020) Table 56. North America Influenza Vaccines Revenue by Country (2015-2020) (US$ Million) Table 57. North America Influenza Vaccines Revenue Market Share by Country (2015-2020) Table 58. Europe Influenza Vaccines Sales by Country (2015-2020) (K Units) Table 59. Europe Influenza Vaccines Sales Market Share by Country (2015-2020) Table 60. Europe Influenza Vaccines Revenue by Country (2015-2020) (US$ Million) Table 61. Europe Influenza Vaccines Revenue Market Share by Country (2015-2020) Table 62. Asia Pacific Influenza Vaccines Sales by Region (2015-2020) (K Units) Table 63. Asia Pacific Influenza Vaccines Sales Market Share by Region (2015-2020) Table 64. Asia Pacific Influenza Vaccines Revenue by Region (2015-2020) (US$ Million) Table 65. Asia Pacific Influenza Vaccines Revenue Market Share by Region (2015-2020) Table 66. Latin America Influenza Vaccines Sales by Country (2015-2020) (K Units) Table 67. Latin America Influenza Vaccines Sales Market Share by Country (2015-2020) Table 68. Latin Americaa Influenza Vaccines Revenue by Country (2015-2020) (US$ Million) Table 69. Latin America Influenza Vaccines Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Influenza Vaccines Sales by Country (2015-2020) (K Units) Table 71. Middle East and Africa Influenza Vaccines Sales Market Share by Country (2015-2020) Table 72. Middle East and Africa Influenza Vaccines Revenue by Country (2015-2020) (US$ Million) Table 73. Middle East and Africa Influenza Vaccines Revenue Market Share by Country (2015-2020) Table 74. AstraZeneca Corporation Information Table 75. AstraZeneca Description and Business Overview Table 76. AstraZeneca Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 77. AstraZeneca Influenza Vaccines Product Table 78. AstraZeneca Recent Development Table 79. CSL Corporation Information Table 80. CSL Description and Business Overview Table 81. CSL Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 82. CSL Product Table 83. CSL Recent Development Table 84. GlaxoSmithKline Corporation Information Table 85. GlaxoSmithKline Description and Business Overview Table 86. GlaxoSmithKline Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 87. GlaxoSmithKline Product Table 88. GlaxoSmithKline Recent Development Table 89. Sanofi Corporation Information Table 90. Sanofi Description and Business Overview Table 91. Sanofi Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 92. Sanofi Product Table 93. Sanofi Recent Development Table 94. Altimmune Corporation Information Table 95. Altimmune Description and Business Overview Table 96. Altimmune Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 97. Altimmune Product Table 98. Altimmune Recent Development Table 99. BionVax Corporation Information Table 100. BionVax Description and Business Overview Table 101. BionVax Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 102. BionVax Product Table 103. BionVax Recent Development Table 104. FluGen Corporation Information Table 105. FluGen Description and Business Overview Table 106. FluGen Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 107. FluGen Product Table 108. FluGen Recent Development Table 109. FOLIA BIOTECH Corporation Information Table 110. FOLIA BIOTECH Description and Business Overview Table 111. FOLIA BIOTECH Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 112. FOLIA BIOTECH Product Table 113. FOLIA BIOTECH Recent Development Table 114. Genentech Corporation Information Table 115. Genentech Description and Business Overview Table 116. Genentech Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 117. Genentech Product Table 118. Genentech Recent Development Table 119. Green Cross Corporation Information Table 120. Green Cross Description and Business Overview Table 121. Green Cross Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 122. Green Cross Product Table 123. Green Cross Recent Development Table 124. Medicago Corporation Information Table 125. Medicago Description and Business Overview Table 126. Medicago Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 127. Medicago Product Table 128. Medicago Recent Development Table 129. Moderna Therapeutics Corporation Information Table 130. Moderna Therapeutics Description and Business Overview Table 131. Moderna Therapeutics Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 132. Moderna Therapeutics Product Table 133. Moderna Therapeutics Recent Development Table 134. Novavax Corporation Information Table 135. Novavax Description and Business Overview Table 136. Novavax Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 137. Novavax Product Table 138. Novavax Recent Development Table 139. Shijiazhuang Yiling Pharmaceutical Corporation Information Table 140. Shijiazhuang Yiling Pharmaceutical Description and Business Overview Table 141. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 142. Shijiazhuang Yiling Pharmaceutical Product Table 143. Shijiazhuang Yiling Pharmaceutical Recent Development Table 144. SK Chemicals Corporation Information Table 145. SK Chemicals Description and Business Overview Table 146. SK Chemicals Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 147. SK Chemicals Product Table 148. SK Chemicals Recent Development Table 149. UNM Pharma Corporation Information Table 150. UNM Pharma Description and Business Overview Table 151. UNM Pharma Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 152. UNM Pharma Product Table 153. UNM Pharma Recent Development Table 154. Vaccitech Corporation Information Table 155. Vaccitech Description and Business Overview Table 156. Vaccitech Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 157. Vaccitech Product Table 158. Vaccitech Recent Development Table 159. Vaxart Corporation Information Table 160. Vaxart Description and Business Overview Table 161. Vaxart Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 162. Vaxart Product Table 163. Vaxart Recent Development Table 164. Vaxine Pty Corporation Information Table 165. Vaxine Pty Description and Business Overview Table 166. Vaxine Pty Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 167. Vaxine Pty Product Table 168. Vaxine Pty Recent Development Table 169. Visterra Corporation Information Table 170. Visterra Description and Business Overview Table 171. Visterra Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 172. Visterra Product Table 173. Visterra Recent Development Table 174. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 175. Key Challenges Table 176. Market Risks Table 177. Main Points Interviewed from Key Influenza Vaccines Players Table 178. Influenza Vaccines Customers List Table 179. Influenza Vaccines Distributors List Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Influenza Vaccines Product Picture Figure 2. Global Influenza Vaccines Sales Market Share by Type in 2020 & 2026 Figure 3. Trivalent Flu Vaccines Product Picture Figure 4. Quadrivalent Flu Vaccines Product Picture Figure 5. Global Influenza Vaccines Sales Market Share by Application in 2020 & 2026 Figure 6. Adults Figure 7. Pediatrics Figure 8. Influenza Vaccines Report Years Considered Figure 9. Global Influenza Vaccines Market Size 2015-2026 (US$ Million) Figure 10. Global Influenza Vaccines Sales 2015-2026 (K Units) Figure 11. Global Influenza Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Global Influenza Vaccines Sales Market Share by Region (2015-2020) Figure 13. Global Influenza Vaccines Sales Market Share by Region in 2019 Figure 14. Global Influenza Vaccines Revenue Market Share by Region (2015-2020) Figure 15. Global Influenza Vaccines Revenue Market Share by Region in 2019 Figure 16. Global Influenza Vaccines Sales Share by Manufacturer in 2019 Figure 17. The Top 10 and 5 Players Market Share by Influenza Vaccines Revenue in 2019 Figure 18. Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Influenza Vaccines Sales Market Share by Type (2015-2020) Figure 20. Global Influenza Vaccines Sales Market Share by Type in 2019 Figure 21. Global Influenza Vaccines Revenue Market Share by Type (2015-2020) Figure 22. Global Influenza Vaccines Revenue Market Share by Type in 2019 Figure 23. Global Influenza Vaccines Market Share by Price Range (2015-2020) Figure 24. Global Influenza Vaccines Sales Market Share by Application (2015-2020) Figure 25. Global Influenza Vaccines Sales Market Share by Application in 2019 Figure 26. Global Influenza Vaccines Revenue Market Share by Application (2015-2020) Figure 27. Global Influenza Vaccines Revenue Market Share by Application in 2019 Figure 28. United States Influenza Vaccines Sales Growth Rate 2015-2026 (K Units) Figure 29. United States Influenza Vaccines Revenue Growth Rate 2015-2026 (US$ Million) Figure 30. United States Influenza Vaccines Market Share in Global Market 2015-2026 Figure 31. United States 5 and 10 Largest Influenza Vaccines Players Market Share by Revenue in Influenza Vaccines in 2019 Figure 32. United States Influenza Vaccines Revenue Share by Type (2015-2020) Figure 33. United States Influenza Vaccines Revenue Growth Rate by Type in 2015 & 2019 Figure 34. United States Influenza Vaccines Revenue Share by Application (2015-2020) Figure 35. United States Influenza Vaccines Revenue Growth Rate by Application in 2015 & 2019 Figure 36. North America Influenza Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 37. North America Influenza Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 38. North America Influenza Vaccines Sales Market Share by Country in 2019 Figure 39. North America Influenza Vaccines Revenue Market Share by Country in 2019 Figure 40. U.S. Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 41. U.S. Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Canada Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 43. Canada Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Europe Influenza Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 45. Europe Influenza Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 46. Europe Influenza Vaccines Sales Market Share by Country in 2019 Figure 47. Europe Influenza Vaccines Revenue Market Share by Country in 2019 Figure 48. Germany Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 49. Germany Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. France Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 51. France Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. U.K. Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 53. U.K. Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Italy Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 55. Italy Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Russia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 57. Russia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Asia Pacific Influenza Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 59. Asia Pacific Influenza Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 60. Asia Pacific Influenza Vaccines Sales Market Share by Region in 2019 Figure 61. Asia Pacific Influenza Vaccines Revenue Market Share by Region in 2019 Figure 62. China Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 63. China Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Japan Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 65. Japan Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. South Korea Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 67. South Korea Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. India Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 69. India Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Australia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 71. Australia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Taiwan Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 73. Taiwan Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Indonesia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 75. Indonesia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Thailand Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 77. Thailand Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Malaysia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 79. Malaysia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Philippines Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 81. Philippines Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Vietnam Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 83. Vietnam Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Latin America Influenza Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 85. Latin America Influenza Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 86. Latin America Influenza Vaccines Sales Market Share by Country in 2019 Figure 87. Latin America Influenza Vaccines Revenue Market Share by Country in 2019 Figure 88. Mexico Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 89. Mexico Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Brazil Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 91. Brazil Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Argentina Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 93. Argentina Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Middle East and Africa Influenza Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 95. Middle East and Africa Influenza Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 96. Middle East and Africa Influenza Vaccines Sales Market Share by Country in 2019 Figure 97. Middle East and Africa Influenza Vaccines Revenue Market Share by Country in 2019 Figure 98. Turkey Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 99. Turkey Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 100. Saudi Arabia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 101. Saudi Arabia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. U.A.E Influenza Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 103. U.A.E Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Porter's Five Forces Analysis Figure 105. Influenza Vaccines Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Protein Sequencing Market Size, Status and Forecast 2021-2027

Protein Sequencing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Protein Sequencing market will be able to gain the upper hand as they use the report as a po...

Global Automotive Simulation Market Size, Status and Forecast 2021-2027

Automotive Simulation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Automotive Simulation market will be able to gain the upper hand as they use the report a...

Global Allergy Care Market Size, Status and Forecast 2021-2027

Allergy Care market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Allergy Care market will be able to gain the upper hand as they use the report as a powerful resou...

Global Enterprise Architecture Software Market Size, Status and Forecast 2021-2027

Enterprise Architecture Software market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enterprise Architecture Software market will be able to gain the upper hand as...

Global Emissions Management Software Market Size, Status and Forecast 2021-2027

Emissions Management Software market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Emissions Management Software market will be able to gain the upper hand as they ...

Publisher: QY Research
Chat with us